No Data
Shanghai Kinetic Medical Co., Ltd (SZSE:300326) Is Going Strong But Fundamentals Appear To Be Mixed : Is There A Clear Direction For The Stock?
Kelly Thai: Q3 2024 Report
shanghai kinetic medical (300326.SZ): net income in the third quarter was 25.8278 million yuan, a year-on-year increase of 78.69%.
shanghai kinetic medical (300326.SZ) released the third quarter report for 2024 on October 23. During the reporting period, the revenue was 0.274 billion yuan, an increase of 28.29% year-on-year; the net income attributable to shareholders of the listed company was 25.8278 million yuan, an increase of 78.69% year-on-year; the net income attributable to shareholders of the listed company after deducting non-recurring gains and losses was 19.2125 million yuan, an increase of 62.25% year-on-year; the basic earnings per share was 0.0360 yuan.
Even With A 30% Surge, Cautious Investors Are Not Rewarding Shanghai Kinetic Medical Co., Ltd's (SZSE:300326) Performance Completely
shanghai kinetic medical (300326.SZ): Currently there are no similar allogeneic bone-related products.
Shanghai Kinetic Medical (300326.SZ) stated on the investor interaction platform on September 12 that the company currently does not have related products made from the same heterologous bone. The company's main implant products include spinal internal fixation products, bone cement, and vertebral fusion devices. The main raw materials for spinal internal fixation products are pure titanium or titanium alloy, the main component of bone cement is polymethyl methacrylate, and the main material for vertebral fusion devices is polyetheretherketone copper.
Kelly Thai: 2024 Semi-Annual Report
Benign Growth For Shanghai Kinetic Medical Co., Ltd (SZSE:300326) Underpins Stock's 26% PlummetNo Data
No Data
